Biofrontera Inc.
BFRI
$0.7874
-$0.0136-1.70%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.40M | -5.67M | -257.00K | -10.44M | 3.53M |
| Total Depreciation and Amortization | 221.00K | 312.00K | 309.00K | 307.00K | 295.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 50.00K | 1.01M | -5.11M | 4.19M | -7.44M |
| Change in Net Operating Assets | 108.00K | 3.14M | 342.00K | 2.62M | -5.25M |
| Cash from Operations | -1.02M | -1.21M | -4.72M | -3.33M | -8.87M |
| Capital Expenditure | -1.00K | 0.00 | 48.00K | -57.00K | 9.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | -50.00K | 57.00K | 64.00K |
| Cash from Investing | -1.00K | 0.00 | -2.00K | 0.00 | 73.00K |
| Total Debt Issued | 4.05M | -- | -- | -- | 11.70M |
| Total Debt Repaid | 0.00 | -298.00K | -2.15M | -1.86M | -9.50M |
| Issuance of Common Stock | 0.00 | 0.00 | 7.44M | 7.66M | 4.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.05M | -298.00K | 5.28M | 5.80M | 6.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.03M | -1.51M | 562.00K | 2.47M | -2.08M |
